Phillips Carbon announces Q2 results; stock closes higher by 2.98 per cent
Phillips Carbon announces Q2 results; stock closes higher by 2.98 per cent

Phillips Carbon announces Q2 results; stock closes higher by 2.98 per cent

Rishikesh Gaikwad Article rating: 2.5

Philips Carbon Black Limited (PCBL) reported its September quarter results today.Profit before tax for the company stood at Rs 72.47 crore in Q2FY21, which is 28.9 per cent lesser than the corresponding quarter last year. Profit after tax for Q2FY21 stood at Rs 57.55 crore, showing a YoY decrease of 25 per cent

Alembic Pharma gets USFDA approval for Amantadine Hydrochloride tablets
Alembic Pharma gets USFDA approval for Amantadine Hydrochloride tablets

Alembic Pharma gets USFDA approval for Amantadine Hydrochloride tablets

Chinmayee D Article rating: 3.6

The drug is indicated for the prophylaxis of signs and symptoms of infection caused by various strains of influenza A virus and is also used in the treatment of parkinsonism and drug-induced extrapyramidal reactions.

AstraZeneca Pharma India plans to launch cancer drug; stock opens positive
AstraZeneca Pharma India plans to launch cancer drug; stock opens positive

AstraZeneca Pharma India plans to launch cancer drug; stock opens positive

Chinmayee D Article rating: 5.0

Acalabrutinib 100 mg capsules (Calquence) are used to treat patients suffering from mantle cell lymphoma (MCL) especially those, who have received at least one prior therapy. It is also used for the treatment of chronic lymphocytic leukaemia (CLL)/small lymphocytic lymphoma (SLL).

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 4.2

The market opened in green October 16, 2020, overall volumes in futures & options currently stand at 8,37,12,303 contracts with a turnover of Rs. 58,24,762.54 crore.

RSS
First23842385238623872389239123922393Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR